Language

English

Publication Date

1-1-2026

Journal

Frontiers in Oncology

DOI

10.3389/fonc.2026.1796311

PMID

42444820

PMCID

PMC13357122

PubMedCentral® Posted Date

6-29-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Introduction: Immune deficiency and infection with human herpesvirus-8 (HHV-8) are established component causes of Kaposi sarcoma (KS), but they are insufficient to cause disease in most people at risk. Therefore, we hypothesized that genetic variation may contribute to KS risk in children and adults, as well as contribute to its unique epidemiology in sub-Saharan Africa.

Methods: To test this hypothesis, we conducted a two-phase genome-wide association study (GWAS): a discovery study in perinatally HIV-infected children (45 KS cases, 91 controls), followed by validation of significant results in a sample of adults living with HIV (215 cases, 262 controls). After standard quality control, we tested single-nucleotide variants for association with KS.

Results: In children, the top signal was a missense variant in the mitochondrial antiviral-signaling (MAVS) gene (rs7269320), which showed a suggestive allelic association with KS (OR 3.8, 95% CI 2.2 -6.7, p=9.7×10-7). In the adult validation study, the same MAVS variant was again associated with KS, indicating a recessive inheritance pattern (OR 2.2, 95% CI 1.2 -3.9, p=0.006). MAVS is a component of the RIG-I/MAVS signaling pathway and a biologically plausible genetic variant contributing to KS oncogenesis. MAVS protein deficiency/dysfunction is known to impair the antiviral cytokine response to HHV-8 infection and enhance its reactivation.

Discussion: These findings provide the first pediatric evidence of germline susceptibility to KS and suggest RIG-I/MAVS as a candidate pathway for host risk. Further replication and functional studies are needed to clarify the mechanism underlying the risk associated with MAVS and to assess whether it could be used to identify individuals at the highest risk for KS in high-burden settings and/or be leveraged as a novel therapeutic strategy.

Keywords

HHV-8, HIV-associated cancers, KS, KSHV, LMIC, MAVS, RIG-I

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.